NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $257,699 | -17.6% | 4,285 | +0.5% | 0.00% | -33.3% |
| Q4 2022 | $312,691 | -1.7% | 4,263 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $318,000 | +14.0% | 4,191 | +4.4% | 0.00% | +50.0% |
| Q2 2022 | $279,000 | -20.1% | 4,014 | -4.8% | 0.00% | 0.0% |
| Q1 2022 | $349,000 | -32.8% | 4,218 | +80.3% | 0.00% | -50.0% |
| Q2 2021 | $519,000 | +76.5% | 2,340 | +5.3% | 0.00% | +100.0% |
| Q1 2021 | $294,000 | -13.3% | 2,222 | +13.4% | 0.00% | -33.3% |
| Q4 2020 | $339,000 | – | 1,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |